The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Lethal, Hereditary Mutants of Phospholamban Elude Phosphorylation by Protein Kinase A
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It should be noted, however, that these aberrant mutants are recalcitrant to phosphorylation and display a dysfunctional β-adrenergic response in vivo [75].”
From Pathological mutations in the phospholamban cytoplasmic region affect its topology and dynamics modulating the extent of SERCA inhibition (2024) · cites this paper as [75]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alterations of Sarcoplasmic Reticulum Proteins in Failing Human Dilated Cardiomyopathy
Meyer, M., Schillinger, W., Pieske, B., Holubarsch, C., Heilmann, C., Posival, H., Kuwajima, G., Mikoshiba, K., Just, H., & Hasenfuss, G. (1995) · Circulation · doi:10.1161/01.cir.92.4.778 · Cited by 535
Research works printed but not linked: 49
- Tada, 1976, Regulation of calcium transport in cardiac sarcoplasmic reticulum by cyclic AMP-dependent protein kinase, Recent Adv. Stud. Cardiac Struct. Metab., 9, 225
- Morgan, 1991, Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction, N. Engl. J. Med., 325, 625, 10.1056/NEJM199108293250906 · DOI · Paper page
- Simmerman, 1986, Sequence analysis of phospholamban. Identification of phosphorylation sites and two major structural domains, J. Biol. Chem., 261, 13333, 10.1016/S0021-9258(18)69309-3 · doi:10.1016/s0021-9258(18)69309-3
- Schmidt, 2001, Phospholamban. A promising therapeutic target in heart failure?, Cardiovasc. Drugs Ther., 15, 387, 10.1023/A:1013381204658 · DOI
- Grünig, 1998, Frequency and phenotypes of familial dilated cardiomyopathy, J. Am. Coll. Cardiol., 31, 186, 10.1016/S0735-1097(97)00434-8 · DOI · Paper page
- Brittsan, 2000, Phospholamban and cardiac contractile function, J. Mol. Cell Cardiol., 32, 2131, 10.1006/jmcc.2000.1270 · DOI · Paper page
- Luo, 1996, Phospholamban gene dosage effects in the mammalian heart, Circ. Res., 78, 839, 10.1161/01.RES.78.5.839 · DOI
- Frank, 2002, Modulation of SERCA. Implications for the failing human heart, Basic Res. Cardiol., 97, I72, 10.1007/s003950200033 · DOI
- Haghighi, 2006, A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy, Proc. Natl. Acad. Sci. U.S.A., 103, 1388, 10.1073/pnas.0510519103 · DOI · Paper page
- Haghighi, 2003, Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human, J. Clin. Invest., 111, 869, 10.1172/JCI17892 · DOI · Paper page
- Schmitt, 2003, Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban, Science, 299, 1410, 10.1126/science.1081578 · DOI · Paper page
- Medeiros, 2011, Mutations in the human phospholamban gene in patients with heart failure, Am. Heart J., 162, 1088, 10.1016/j.ahj.2011.07.028 · DOI
- Haghighi, 2001, Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure, J. Biol. Chem., 276, 24145, 10.1074/jbc.M102403200 · DOI
- Zhai, 2000, Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo, J. Biol. Chem., 275, 10538, 10.1074/jbc.275.14.10538 · DOI
- Zvaritch, 2000, The transgenic expression of highly inhibitory monomeric forms of phospholamban in mouse heart impairs cardiac contractility, J. Biol. Chem., 275, 14985, 10.1074/jbc.275.20.14985 · DOI
- Kimura, 1996, Phospholamban regulates the Ca2+-ATPase through intramembrane interactions, J. Biol. Chem., 271, 21726, 10.1074/jbc.271.36.21726 · DOI
- Fujii, 1989, Expression and site-specific mutagenesis of phospholamban. Studies of residues involved in phosphorylation and pentamer formation, J. Biol. Chem., 264, 12950, 10.1016/S0021-9258(18)51579-9 · doi:10.1016/s0021-9258(18)51579-9
- Ceholski, 2012, Hydrophobic imbalance in the cytoplasmic domain of phospholamban is a determinant for lethal dilated cardiomyopathy, J. Biol. Chem., 287, 16521, 10.1074/jbc.M112.360859 · DOI · Paper page
- Eletr, 1972, Phospholipid orientation in sarcoplasmic membranes. Spin-label ESR and proton MNR studies, Biochim. Biophys. Acta, 282, 174, 10.1016/0005-2736(72)90321-5 · DOI · Paper page
- Stokes, 1990, Three-dimensional crystals of CaATPase from sarcoplasmic reticulum. Symmetry and molecular packing, Biophys. J., 57, 1, 10.1016/S0006-3495(90)82501-7 · DOI
- Douglas, 2005, Rapid, high-yield expression and purification of Ca2+-ATPase regulatory proteins for high-resolution structural studies, Protein Expr. Purif., 40, 118, 10.1016/j.pep.2004.11.015 · doi:10.1016/j.pep.2004.11.015
- Trieber, 2005, The effects of mutation on the regulatory properties of phospholamban in co-reconstituted membranes, Biochemistry, 44, 3289, 10.1021/bi047878d · doi:10.1021/bi047878d
- Young, 1998, Co-reconstitution and co-crystallization of phospholamban and Ca2+-ATPase, Ann. N.Y. Acad. Sci., 853, 103, 10.1111/j.1749-6632.1998.tb08260.x · doi:10.1111/j.1749-6632.1998.tb08260.x
- Warren, 1974, Reconstitution of a calcium pump using defined membrane components, Proc. Natl. Acad. Sci. U.S.A., 71, 622, 10.1073/pnas.71.3.622 · DOI · Paper page
- Young, 1997, How to make tubular crystals by reconstitution of detergent-solubilized Ca2+-ATPase, Biophys. J., 72, 2545, 10.1016/S0006-3495(97)78898-2 · DOI
- Young, 2001, Locating phospholamban in co-crystals with Ca2+-ATPase by cryoelectron microscopy, Biophys. J., 81, 884, 10.1016/S0006-3495(01)75748-7 · DOI
- Studier, 2005, Protein production by auto-induction in high density shaking cultures, Protein Expr. Purif., 41, 207, 10.1016/j.pep.2005.01.016 · DOI · Paper page
- Hastie, 2006, Assay of protein kinases using radiolabeled ATP. A protocol, Nat. Protoc., 1, 968, 10.1038/nprot.2006.149 · DOI · Paper page
- Hasenfuss, 1994, Relation between myocardial function and expression of sarcoplasmic reticulum Ca2+-ATPase in failing and nonfailing human myocardium, Circ. Res., 75, 434, 10.1161/01.RES.75.3.434 · DOI · Paper page
- Moore, 2003, Structural basis for peptide binding in protein kinase A. Role of glutamic acid 203 and tyrosine 204 in the peptide-positioning loop, J. Biol. Chem., 278, 10613, 10.1074/jbc.M210807200 · DOI
- Toyofuku, 1994, Amino acids Glu2 to Ile18 in the cytoplasmic domain of phospholamban are essential for functional association with the Ca2+-ATPase of sarcoplasmic reticulum, J. Biol. Chem., 269, 3088, 10.1016/S0021-9258(17)42051-5 · DOI · Paper page
- Lygren, 2007, AKAP complex regulates Ca2+ re-uptake into heart sarcoplasmic reticulum, EMBO Rep., 8, 1061, 10.1038/sj.embor.7401081 · DOI · Paper page
- Neuberger, 2007, pkaPS. Prediction of protein kinase A phosphorylation sites with the simplified kinase-substrate binding model, Biol. Direct, 2, 1, 10.1186/1745-6150-2-1 · DOI · Paper page
- Masterson, 2010, Dynamics connect substrate recognition to catalysis in protein kinase A, Nat. Chem. Biol., 6, 821, 10.1038/nchembio.452 · DOI · Paper page
- Kemp, 1977, Role of multiple basic residues in determining the substrate specificity of cyclic AMP-dependent protein kinase, J. Biol. Chem., 252, 4888, 10.1016/S0021-9258(17)40137-2 · DOI · Paper page
- Li, 1990, Immunological detection of phospholamban phosphorylation states facilitates the description of the mechanism of phosphorylation and dephosphorylation, Biochemistry, 29, 4535, 10.1021/bi00471a005 · DOI
- DeWitt, 2006, Phospholamban R14 deletion results in late-onset, mild, hereditary dilated cardiomyopathy, J. Am. Coll. Cardiol., 48, 1396, 10.1016/j.jacc.2006.07.016 · DOI
- Posch, 2009, Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes, Heart Rhythm, 6, 480, 10.1016/j.hrthm.2009.01.016 · doi:10.1016/j.hrthm.2009.01.016
- Haghighi, 2012, The human phospholamban Arg14-deletion mutant localizes to plasma membrane and interacts with the Na/K-ATPase, J. Mol. Cell. Cardiol., 52, 773, 10.1016/j.yjmcc.2011.11.012 · DOI
- Kho, 2011, SUMO1-dependent modulation of SERCA2a in heart failure, Nature, 477, 601, 10.1038/nature10407 · DOI · Paper page
- Ha, 2011, Lethal Arg9Cys phospholamban mutation hinders Ca2+-ATPase regulation and phosphorylation by protein kinase A, Proc. Natl. Acad. Sci. U.S.A., 108, 2735, 10.1073/pnas.1013987108 · DOI
- Shabb, 2001, Physiological substrates of cAMP-dependent protein kinase, Chem. Rev., 101, 2381, 10.1021/cr000236l · DOI · Paper page
- Minamisawa, 1999, Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy, Cell, 99, 313, 10.1016/S0092-8674(00)81662-1 · DOI · Paper page
- Kass, 1998, Murine cardiac function. A cautionary tail, Circ. Res., 82, 519, 10.1161/01.RES.82.4.519 · DOI · Paper page
- del Monte, 1999, Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a, Circulation, 100, 2308, 10.1161/01.CIR.100.23.2308 · DOI · Paper page
- Paterlini, 2005, The α-helical propensity of the cytoplasmic domain of phospholamban. A molecular dynamics simulation of the effect of phosphorylation and mutation, Biophys. J., 88, 3243, 10.1529/biophysj.104.054460 · doi:10.1529/biophysj.104.054460
- Zamoon, 2003, NMR solution structure and topological orientation of monomeric phospholamban in dodecylphosphocholine micelles, Biophys. J., 85, 2589, 10.1016/S0006-3495(03)74681-5 · DOI
- Knighton, 1991, Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase, Science, 253, 414, 10.1126/science.1862343 · DOI · Paper page
- Masterson, 2011, Dynamically committed, uncommitted, and quenched states encoded in protein kinase A revealed by NMR spectroscopy, Proc. Natl. Acad. Sci. U.S.A., 108, 6969, 10.1073/pnas.1102701108 · DOI · Paper page
Cited by
Gorski, P. A., Ceholski, D. K., & Hajjar, R. J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.01.005 · Cited by 213
Self-citationMorales, A., Kinnamon, D. D., Jordan, E., Platt, J., Vatta, M., Dorschner, M. O., Starkey, C. A., Mead, J. O., Ai, T., Burke, W., et al. (2020) · Circulation: Genomic and Precision Medicine · doi:10.1161/circgen.119.002480 · Cited by 114
Weber, D. K., Reddy, U. V., Robia, S. L., & Veglia, G. (2024) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2024.184370 · Cited by 8
Metadata
- Authors
- Ceholski, D. K., Trieber, C. A., Holmes, C. F. B., & Young, H. S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2012-08
- Volume
- 287
- Issue
- 32
- Pages
- 26596-26605
- ISSN
- 0021-9258
- Cited by
- 57
- References
- 1
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 2960 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.